Yokohama R&D Center, JNC CORPORATION, 5-1, Ookawa, Kanazawa-ku, Yokohama, 236-8605, Japan.
Yokohama R&D Center, JNC CORPORATION, 5-1, Ookawa, Kanazawa-ku, Yokohama, 236-8605, Japan.
J Chromatogr A. 2024 Sep 13;1732:465202. doi: 10.1016/j.chroma.2024.465202. Epub 2024 Jul 21.
Despite advancements in therapeutic monoclonal antibodies (mAbs) and cell line engineering, separating host cell proteins (HCPs) from mAbs during downstream purification remains challenging. Therefore, in this study, we developed a novel multimodal chromatography (MMC) resin to enhance HCP removal during mAb polishing processes. We evaluated the impact of both ligand structure and pore size of the MMC resin by purifying a post-protein A chromatography solution in flow-through mode. We observed that the efficiency of HCP clearance depended on the hydrophobic moiety structure of the ligand and predicted the mAb purification capability of MMC through linear salt-gradient elution experiments involving a mixture of transferrin, bovine serum albumin (BSA), and pepsin. Our findings revealed that the prototype immobilized 1,12-dodecanediamine via the formyl group exhibited the best performance attributed to its long alkyl chain. Furthermore, an investigation of effects of base bead pore size on HCP capacity using cellulose base beads of five different pore sizes showed that larger pore resin base beads had the highest HCP removal capacity. Specifically, MMC resins with a pore diameter exceeding 440 nm reduced the HCP level by three orders of magnitude under high mAb loading conditions (> 1000 mg/mL-resin). The MMC resin developed in this study, along with the insights gained into ligand structure and pore size, not only enhances mAb polishing efficiency but also contributes to improving downstream processes in mAb biopharmaceutical production.
尽管治疗性单克隆抗体(mAbs)和细胞系工程取得了进展,但在下游纯化过程中从 mAbs 中分离宿主细胞蛋白(HCPs)仍然具有挑战性。因此,在这项研究中,我们开发了一种新型多模式色谱(MMC)树脂,以增强 mAb 抛光过程中 HCP 的去除效率。我们通过在流穿模式下纯化蛋白 A 层析后的洗脱液来评估 MMC 树脂的配体结构和孔径对 HCP 清除效率的影响。我们观察到 HCP 清除效率取决于配体的疏水性部分结构,并通过涉及转铁蛋白、牛血清白蛋白(BSA)和胃蛋白酶的混合溶液的线性盐梯度洗脱实验预测了 MMC 对 mAb 的纯化能力。我们的研究结果表明,通过甲酰基固定的原型 1,12-十二二胺因其长烷基链而表现出最佳性能。此外,使用五种不同孔径的纤维素基质珠研究基质珠孔径对 HCP 容量的影响表明,较大孔径的树脂基质珠具有最高的 HCP 去除能力。具体来说,在高 mAb 载量条件(>1000mg/mL-树脂)下,孔径超过 440nm 的 MMC 树脂可将 HCP 水平降低三个数量级。本研究开发的 MMC 树脂以及对配体结构和孔径的深入了解,不仅提高了 mAb 抛光效率,还有助于改善 mAb 生物制药生产中的下游工艺。